Filing Analysis
Alector, Inc. entered into an at-the-market (ATM) sales agreement with TD Securities (USA) LLC to potentially sell up to $125 million of its common stock. The company intends to use any proceeds for general corporate purposes, including research, development, and manufacturing of its product candidates.
Red Flags
- Potential for significant shareholder dilution if the full $125 million is utilized.
- Reliance on equity markets to fund ongoing R&D and manufacturing operations.
Key Facts
- Agreement entered on May 7, 2026, with TD Securities (USA) LLC (TD Cowen).
- Maximum aggregate offering price of $125,000,000 in common stock.
- TD Cowen will receive a commission of up to 3.0% of the gross sales price.
- The offering is conducted under an existing shelf registration statement on Form S-3 (File No. 333-294241).
- Alector is not obligated to sell any shares and can terminate the agreement with 10 days' notice.
Alector, Inc. announced its financial results for the first quarter ended March 31, 2026. The announcement was made via a press release furnished as an exhibit to the filing.
Key Facts
- Financial results for the quarter ended March 31, 2026, were announced on May 7, 2026.
- The filing includes Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Exhibits).
- The information is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act.
Alector, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. The filing serves as a standard disclosure of the company's periodic financial performance via a press release.
Key Facts
- Reported financial results for the quarter ended December 31, 2025, on February 25, 2026.
- The filing was made under Item 2.02 (Results of Operations and Financial Condition).
- Included Exhibit 99.1, which is the press release detailing the financial results.